Lar de Fermentelos
Águeda Municipality, Portugal
NCT Number: NCT03493308
The primary objectives of this study are to:
* Evaluate recruitment procedures and adherence rates; * Evaluate the ability to understand the concepts of pain neurophysiology; * Evaluate the acceptability of an intervention program based on pain neuroscience education and exercise by institutionalized older adults and the institutions where they are.
Looking for future studies?
Notify Me65 year and older
All sexes
Interventional
Not applicable
Águeda Municipality, Portugal
Participants will be older adults with pain that are institutionalized and assess the feasibility of implementing an intervention consisting of pain neuroscience education in addition to exercise. It is antecipated that the intervention will consist of 1 to 2 sessions per week during 8 weeks and will be delivered in small groups. Participants will be assessed for pain intensity, duration, catastrophizing, fear of movement, knowledge of pain neuroscience, depression and performance.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
PNE will be conducted in line with international guidelines and will cover the neurophysiology of pain, transition from acute to chronic pain and the nervous system ability to modulate the pain experience.
Exercise will be provided in different formats including general exercise, strengthening, dance.
Time frame: Baseline
Assessed using the vertical numeric rating scale that assesses pain intensity (range 0-10 and higher values are indicative of higher pain intensity)
Time frame: 9 weeks
Assessed using the vertical numeric rating scale that assesses pain intensity (range 0-10 and higher values are indicative of higher pain intensity)
Time frame: 3 months
Assessed using the vertical numeric rating scale that assesses pain intensity (range 0-10 and higher values are indicative of higher pain intensity)
Time frame: Baseline
Assessed using a body chart where the patients identifies the painful body segments
Time frame: 9 weeks
Assessed using a body chart where the patients identifies the painful body segments
Time frame: 3 months
Assessed using a body chart where the patients identifies the painful body segments
Time frame: Baseline
Assessed using a closed question on pain frequency for the last week
Time frame: 9 weeks
Assessed using a closed question on pain frequency for the last week
Time frame: 3 months
Assessed using a closed question on pain frequency for the last week
Time frame: Baseline
Assessed using the Geriatric Depression Scale (range 0-15 and values of 5 or higher are indicative of depression)
Time frame: 9 weeks
Assessed using the Geriatric Depression Scale (range 0-15 and values of 5 or higher are indicative of depression)
Time frame: 3 months
Assessed using the Geriatric Depression Scale (range 0-15 and values of 5 or higher are indicative of depression)
Time frame: Baseline
Assessed using the pain neurophysiology questionnaire
Time frame: 9 weeks
Assessed using the pain neurophysiology questionnaire (range 0-19 and higher values are indicative of more knowledge on pain neurophysiology)
Time frame: 3 months
Assessed using the pain neurophysiology questionnaire (range 0-19 and higher values are indicative of more knowledge on pain neurophysiology)
Time frame: Baseline
assessed using the Pain Catastrophizing Scale (range 0-52 and higher values are indicative of higher pain catastrophizing)
Time frame: 9 weeks
assessed using the Pain Catastrophizing Scale (range 0-52 and higher values are indicative of higher pain catastrophizing)
Time frame: 3 months
assessed using the Pain Catastrophizing Scale (range 0-52 and higher values are indicative of higher pain catastrophizing)
Time frame: Baseline
Assessed using the TAMPA Scale, which assesses fear of movement (range: 13-52 and higher values are indicative of higher levels of fear of movement)
Time frame: 9 weeks
Assessed using the TAMPA Scale (range: 13-52 and higher values are indicative of higher levels of fear of movement)
Time frame: 3 months
Assessed using the TAMPA Scale (range: 13-52 and higher values are indicative of higher levels of fear of movement)
Time frame: Baseline
Assessed using the gait velocity test - the time, in seconds, that each participant takes to walk 4 meters
Time frame: 9 weeks
Assessed using the gait velocity test - the time, in seconds, that each participant takes to walk 4 meters
Time frame: 3 months
Assessed using the gait velocity test - the time, in seconds, that each participant takes to walk 4 meters
Time frame: Baseline
Assessed using the Timed up and go test - the time, in seconds, that it takes to stand from a chair, walk 3 meters, turn, walk another 3 meters to sit in the chair.
Time frame: 9 weeks
Assessed using the Timed up and go test - the time, in seconds, that it takes to stand from a chair, walk 3 meters, turn, walk another 3 meters to sit in the chair.
Time frame: 3 months
Assessed using the Timed up and go test - the time, in seconds, that it takes to stand from a chair, walk 3 meters, turn, walk another 3 meters to sit in the chair.
Aveiro University
Other
Pain Neuroscience Education and Exercise in Institutionalized Older Adults With Pain: A Feasibility Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07145788
Agnosia, Chronic Pain
Stuttgart, Auerbachstraße 112, Germany
View Trial DetailsNCT07426497
Chronic Pain, Coccydynia
Istanbul, Sisli, Turkey (Türkiye)
View Trial DetailsNCT06931158
Chronic Low-back Pain, Chronic Pain
Providence, Rhode Island, United States
View Trial DetailsNCT06842381
Chronic Pain, Neurologic Manifestations
Almería, Almeria, Spain
View Trial Details